Screening for dyslipidemias in children and adolescents – the evidence supporting the recommendations

Authors

  • Marisa Loio Médica interna de Medicina Geral e Familiar, USF Santa Clara, ACES Grande Porto IV
  • Daniela de Andrade Maia Médica interna de Medicina Geral e Familiar, USF Santa Clara, ACES Grande Porto IV

DOI:

https://doi.org/10.32385/rpmgf.v30i4.11352

Keywords:

Dyslipidemias, Mass Screening, Child, Adolescent

Abstract

Recently, several medical societies have published clinical guidelines on screening for dyslipidemias in children and adolescents, including the Portuguese Directorate General of Health in June 2013. These recommendations have emerged in response to the increasing prevalence of overweight and obesity in childhood. Furthermore, studies have shown that the atherosclerotic process can begin in childhood and that children with dyslipidemias tend to maintain lipid profile disorders in adulthood. However, it is uncertain whether screening for dyslipidemias decreases cardiovascular risk, morbidity, and mortality. This article reviews the different screening strategies proposed by the main medical societies, and analyzes the evidence supporting these recommendations. Clinical guidelines on screening for dyslipidemias are not based on studies showing benefit in the reduction of cardiovascular risk, morbidity or mortality. The need to perform this screening should be considered for the individual patient.

Downloads

Download data is not yet available.

Downloads

Published

2014-07-01

Issue

Vol. 30 No. 4 (2014): Revista Portuguesa de Medicina Geral e Familiar

Section

Opinion and Debate

License

The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.

The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.

 

How to Cite

Screening for dyslipidemias in children and adolescents – the evidence supporting the recommendations. (2014). Portuguese Journal of Family Medicine and General Practice, 30(4), 264-7. https://doi.org/10.32385/rpmgf.v30i4.11352